Victoria H. Tomlinson, Jane Langley, Andrew G. Meal, Gary G. Adams^*

Show more
Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK.
Intensive Care Unit, Lincoln County Hospital, Lincoln, UK.
Insulin and Diabetes Experimental Research (IDER) Group, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK.
Show less

Abstract: Introduction: Critically ill patients can experience stress-induced hyperglycaemia. Glycaemic control therapy (GCT) is administered to control patients’ blood glycaemic levels and reduce the incidence of infection, myocardial infarctions and organ failure. However, there are many factors influencing the effectiveness of glycaemic control for patients. This investigation aimed to review the method of Glycaemic Control Therapy (GCT) used in two hospital settings, to assess the effectiveness of glycaemic control on patients’ blood glycaemic levels and examine any barriers that may be in place. Method: A retnrospective audit was carried out on patients’ case notes in Intensive Care Units (ICU) within the East Midlands, UK. This method prevents the study outcomes being swayed because GCT has already taken place. To reduce selection bias the most recent available case notes were selected. All the patients who were admitted to these adult ICU’s between March and April 2010 had their case notes examined, those who were administered GCT were included in the study, this involved 79 from Hospital A and 50 from Hospital B. The patients’ notes were retrospectively audited. Results: Different glycaemic control protocols were being implemented in each hospital, despite both belonging to the same ICU network. In most incidences, regardless of age, diabetes status or diagnosis, patients were administered the same sliding scale insulin (SSI). It was also found that GCT commenced for 41.9% (n = 52) of ICU patients (across both Hospitals) when glycaemic levels were below the established threshold of 10mmol/L. Additionally, a new glycaemic range has been discovered, where 88.3% (n = 113) of patients (across both Hospitals) receiving GCT were not controlled in hypoglycaemia, normoglycaemia or hyperglycaemia. They had mean blood glycaemic levels maintained between 5.6 - 9.9 mmol/L, now being described as medioglycaemia. Conclusions: The majority of patients receiving GCT were controlled in medioglycaemia and therefore a new comprehensive guideline needs to be developed incorporating this new range. Recommendations also need to be established to adapt the titration regimen to individual patients, to improve the effectiveness and safety of glycaemic control.

Keywords: Glycaemic Control; Intensive Care (ICU) Units; Medioglycaemia; Tight Glycaemic Control

Cite this paper: H. Tomlinson, V. , Langley, J. , G. Meal, A. and G. Adams, G. (2012) “Medioglycaemia”: A new concept in glycaemic control in intensive care (ICU) units?. Journal of Diabetes Mellitus, 2, 361-368. doi: 10.4236/jdm.2012.24056.

References

[1]   Marik, P.E. and Preiser, J.C. (2010) Towards understanding tight glycemic control in the ICU: A systematic review and metaanalysis. Chest, 137, 544-551. doi:10.1378/chest.09-1737

[2]   Spuhler, V.J. and Veale, K.V. (2007) Tighten up glycaemic control: Aggressive insulin therapy in critical care settings is the latest method for reducing mortality rates. Critical Care Insider, 37, 10-13.

[3]   Sage, D. (2009) Glycaemic control: It’s not just about diabetes. Academy of Medical-Surgical Nurses, 18, 11-15.

[4]   Van den Berghe, G., Wouters, P., Weekers, F., et al. (2001) Intensive Insulin Therapy in Critically Ill patients. The New England Journal of Medicine, 345, 1359-1366. doi:10.1056/NEJMoa011300

[5]   Parsons, P. and Watkinson, P. (2007) Blood glucose control in critical care patients—A review of the literature. British Association of Critical Care Nurses, 12, 202-210.

[6]   Pielmeier, U., Andreassen, S., Juliussen, B., Chase, J.G., Nielsen, B.S. and Haure, P. (2010) The Glucosafe system for tight glycaemic control in critical care: A pilot evaluation study. Journal of Critical Care, 25, 97-104. doi:10.1016/j.jcrc.2009.10.003

[7]   Gerstein, H.C. (2010) Prevention of the consequences of diabetes—A commentary. In: Herman, W.H., Kinmonth, A.L., Wareham, N.J. and Williams, R., Eds., The Evidence Base for Diabetes Care, 2nd Edition, Wiley-Blackwell, Oxford, 266-272.

[8]   Bellomo, R.a.E., M., (2009) What is a nice-sugar for patients in the intensive care unit? Mayo Clinic Procedures, 84, 400-402.

[9]   Harper, J. (2007) BAPEN Symposium 6 on ‘Inflammation technology: Putting theory into practice’ Glucose control in the intensive care unit: how it is done. Proceedings of the Nutrition Society, 66, 362-366. doi:10.1017/S0029665107005629

[10]   Siegelaar, S.E., Holleman, F., Hoekstra, J.B.L. and Hans DeVries, J. (2010) Glucose Variability; Does It Matter? Endocrine Reviews, 31, 171-182. doi:10.1210/er.2009-0021

[11]   Anabtawi, A., Hurst, M., Titi, M., Patel, S., Palacio, C. and Rajamani, K. (2010) Incidence of Hypoglycemia with Tight Glycemic Control Protocols: A Comparative Study. Diabetes Technology & Therapeutics, 12, 635-639. doi:10.1089/dia.2010.0009

[12]   Investigators, N.-S. (2009) Intensive versus Conventional Glucose Control in Critically Ill Patients. The New England Journal of Medicine, 360, 1283-1297. doi:10.1056/NEJMoa0810625

[13]   Van den Berghe, G., Wilmer, A., Hermans, G., et al. (2006) Intensive Insulin Therapy in the Medical ICU. New England Journal of Medicine, 354, 449-461. doi:10.1056/NEJMoa052521

[14]   Webater, N.R. and Galley, H.F. (2009) Does strict glucose control improve outcome? British Journal of Anaesthesia, 103, 331-334. doi:10.1093/bja/aep226

[15]   Dellinger, R.P., Levy, M.M., Carlet, J.M., et al. (2008) Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. Critical Care Medicine, 36, 296-327. doi:10.1097/01.CCM.0000298158.12101.41

[16]   Moghissi, E.S., Korytkowski, M.T., DiNardo, M., et al. (2009) American Association of clinical Endocrinologists (AACE) and the American Diabetes Association (ADA) Consensus Statement on inpatient Glycemic Control. AACE/ADA Consensus Statement. Endocrine Practice, 15, 1-11. doi:10.4158/EP09102.RA

[17]   Corbin, A.E., Carmical, D., Goetz, J.A. et al. (2010) One Institution’s Experience in Implementing Protocols for Glycemic Management. Dimensions of Critical Care Nursing, 29, 167-170. doi:10.1097/DCC.0b013e3181de98da

[18]   Ghosh, R. (2009) Clinical audit for doctors. Developmedica, Nottingham.

[19]   Tomlinson, V. (2011) Unpublished Thesis.

[20]   American Diabetes Association (2010) Standards of Medical Care in Diabetes. Diabetes Care, 33, S11-S61. doi:10.2337/dc10-S011

[21]   Meyfroidt, G., Keenan, D.M., Wang, X., Wouters, P.J., Veldhuis, J.D. and Van den Berghe, G. (2010) Dynamic characteristics of blood glucose time series during the course of critical illness: Effects of intensive insulin therapy and relative association with mortality. Critical Care Medicine, 38, 1021-1029. doi:10.1097/CCM.0b013e3181cf710e

[22]   American Diabetes Association (2011) Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 34, S62-S69.

[23]   American Diabetes Association (2011) Standards of Medical Care in Diabetes. Diabetes Care, 34, S11-S61. doi:10.2337/dc11-S011

[24]   Shogbon, A.O. and Levy, S.B. (2010) Intensive glucose control in the management of diabetes mellitus and inpatient hyperglycemia. American Journal of Health-System Pharmacy, 67, 798-805. doi:10.2146/ajhp090211

[25]   Mackenzie, I.M.J., Whitehouse, T. and Nightingale, P.G. (2011) The metrics of glycaemic control in critical care. Intensive Care Medicine, 37, 435-443. doi:10.1007/s00134-010-2103-2